Back to Search
JOHN MEZGER, PHARMD
PHARMD
Pharmacist
NPI: 1659796506Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
SC12264(SC)RP7856(NM)
Research & Publications (19)
Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil.
PMID 19188680·J Clin Oncol·2009
3-trial
Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy.
PMID 18085432·AIDS Behav·2008
2-rct
Randomized phase II trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer.
PMID 18711188·J Clin Oncol·2008
3-trial
A statistical approach for detecting deviations from usual medical care.
PMID 18694149·AMIA Annu Symp Proc·2007
8-other
Open, randomized, phase II study of single-agent gemcitabine and docetaxel as first- and second-line treatment in patients with advanced non-small-cell lung cancer.
PMID 17311688·Clin Lung Cancer·2007
3-trial
Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer.
PMID 16481389·Eur Respir J·2006
3-trial
Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users.
PMID 17133204·J Acquir Immune Defic Syndr·2006
2-rct
Charge separation and efficient light energy conversion in sensitized mesoscopic solar cells based on binary ionic liquids.
PMID 15869308·J Am Chem Soc·2005
8-other
Randomized multicenter phase II study of gemcitabine versus docetaxel as first-line therapy with second-line crossover in advanced-stage non-small-cell lung cancer.
PMID 16354317·Clin Lung Cancer·2005
3-trial
Population-based registration of unselected colorectal cancer patients: five-year survival in the region of Bonn/Rhine-Sieg, Germany.
PMID 15700204·Z Gastroenterol·2005
4-observational
Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication.
PMID 15156426·Clin Infect Dis·2004
3-trial
Oral idarubicin, dexamethasone and vincristine in the treatment of multiple myeloma: final analysis of a phase II trial.
PMID 15020285·Haematologica·2004
3-trial
High-dose chemotherapy with autologous peripheral blood stem cell support for recurrent primary AFP-producing intracranial germinoma.
PMID 19675701·Ger Med Sci·2003
8-other
Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron.
PMID 14504060·Ann Oncol·2003
3-trial
Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.
PMID 12913100·J Clin Oncol·2003
3-trial
Phase II and pharmacologic study of weekly oral paclitaxel plus cyclosporine in patients with advanced non-small-cell lung cancer.
PMID 12454106·J Clin Oncol·2002
3-trial
Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphoma.
PMID 12175690·Eur J Cancer·2002
3-trial
[Neoadjuvant and adjuvant chemotherapy of locally advanced stomach cancer].
PMID 11577750·Onkologie·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2709 CHURCH ST STE A
CONWAY, SC 29526 - Phone
- (843) 365-0301
Quick Facts
- NPI
- 1659796506
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 19
Are you this provider?
Claim Your Profile